Cannabix Technologies Inc (TSE:BLO)
:BLO
BLO Stock Chart & Stats
C$0.60
-C$0.02(-4.76%)
At close: 4:00 PM EST
C$0.60
-C$0.02(-4.76%)
Day’s Range― - ―
52-Week RangeC$0.46 - C$0.95
Previous CloseN/A
Volume15.24K
Average Volume (3M)36.45K
Market Cap
C$89.49M
Enterprise ValueC$87.73M
Total Cash (Recent Filing)C$1.26M
Total Debt (Recent Filing)C$51.31K
Price to Earnings (P/E)―
Beta0.53
Next Earnings
Aug 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding122,584,110
10 Day Avg. Volume30,616
30 Day Avg. Volume36,452
Financial Highlights & Ratios
PEG Ratio-0.30
Price to Book (P/B)27.07
Price to Sales (P/S)0.00
P/FCF Ratio-37.13
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Product Focus & End-market BreadthThe company targets multiple durable end-markets (workplace, law enforcement, personal testing) with breath-based cannabis and alcohol detectors. This multi-use focus supports long-term addressable market diversity and persistent demand tied to safety and enforcement needs, beyond short-term cycles.
Low LeverageRelatively low debt levels reduce immediate solvency pressure and give the company greater flexibility to manage development timelines in a capital-intensive device business. Lower leverage lessens bankruptcy risk and preserves capacity to raise growth capital on better terms when needed.
Ongoing R&D And Device DevelopmentSustained R&D and prototyping in breath collection, sample analysis, and device engineering indicate potential for proprietary technology and product differentiation. In medical-device markets, demonstrated technical capability and IP pipeline can support durable competitive advantage once commercialized.
Bears Say
Very Small TTM RevenueTrailing revenues of roughly $159k signal very limited commercial traction and scale. Such low sales make it difficult to cover fixed product development and G&A costs, increase reliance on financing, and mean commercialization risks remain large over the next several quarters.
Deeply Negative MarginsNegative gross margins indicate the company is not yet covering direct product costs, while extremely negative net margins show persistent operating losses. Without a clear path to margin improvement, profitability remains distant and the capital base will continue to be eroded by ongoing losses.
Consistent Cash Burn And Shrinking EquityConsistent negative operating and free cash flow, plus a materially declining equity/asset base, show the firm is burning cash and diluting balance-sheet strength. Persistent funding dependence raises dilution and execution risk and constrains the ability to scale commercialization or absorb setbacks.
Cannabix Technologies News
BLO FAQ
What was Cannabix Technologies Inc’s price range in the past 12 months?
Cannabix Technologies Inc lowest stock price was C$0.46 and its highest was C$0.95 in the past 12 months.
What is Cannabix Technologies Inc’s market cap?
Cannabix Technologies Inc’s market cap is C$89.49M.
When is Cannabix Technologies Inc’s upcoming earnings report date?
Cannabix Technologies Inc’s upcoming earnings report date is Aug 27, 2026 which is in 139 days.
How were Cannabix Technologies Inc’s earnings last quarter?
Cannabix Technologies Inc released its earnings results on Mar 25, 2026. The company reported -C$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.003.
Is Cannabix Technologies Inc overvalued?
According to Wall Street analysts Cannabix Technologies Inc’s price is currently Overvalued.
Does Cannabix Technologies Inc pay dividends?
Cannabix Technologies Inc does not currently pay dividends.
What is Cannabix Technologies Inc’s EPS estimate?
Cannabix Technologies Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cannabix Technologies Inc have?
Cannabix Technologies Inc has 122,584,110 shares outstanding.
What happened to Cannabix Technologies Inc’s price movement after its last earnings report?
Cannabix Technologies Inc reported an EPS of -C$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -7.317%.
Which hedge fund is a major shareholder of Cannabix Technologies Inc?
Currently, no hedge funds are holding shares in TSE:BLO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Cannabix Technologies Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
17.02%
12-Months-Change
Fundamentals
Return on Equity
-302.99%
Trailing 12-Months
Asset Growth
-38.24%
Trailing 12-Months
Company Description
Cannabix Technologies Inc
Cannabix Technologies Inc., a technology company, develops marijuana breathalyzer for employers, law enforcement, governments, and public in North America. It develops tetrahydrocannabinol breath analyzers, a point of care breath testing tool for the rapid detection of recent cannabis use, as well as breath collection units. The company was formerly known as West Point Resources Inc. and changed its name to Cannabix Technologies Inc. in August 2014. Cannabix Technologies Inc. was incorporated in 2011 and is based in Burnaby, Canada.
Technical Analysis
Options Prices
Currently, No data available
---